

Founded in 2024, Labops Meditechnology operates in the AI sector offering AI-powered solutions to simplify healthcare, including interpreting lab results, planning care, and aiding doctors across Indi...
Company Type:
Bootstrapped
Employee count:
2
Last 90d
2
Last 90d
Web traffic:
192
192
Last 30d
Last 30d
Labops Meditechnology: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders4
- Latest Filing Date30 March 2025
- Funding Events3
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Labops Meditechnology
As of 31 March 2025, Labops Meditechnology's equity is held by 3 shareholders, with the top three being Debditya Mallick, Soumyajit Hui, and Marl Fund II Llc.
Debditya Mallick holds the largest stake in Labops Meditechnology at 40.0% as of 31 March 2025.
As of 31 March 2025, founders collectively hold 80.0% equity in Labops Meditechnology.
As of 31 March 2025, investors collectively hold 5.0% equity in Labops Meditechnology.
Labops Meditechnology's ESOP pool stands at 15.0% of total equity as of 31 March 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links